EMA Authorised: Insuman (Insulin human) — Sanofi-aventis Deutschland GmbH

View source ↗

Summary

The European Medicines Agency authorised Insuman (insulin human) by Sanofi-aventis Deutschland GmbH for the treatment of diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Insuman (Insulin human)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus. MAH: Sanofi-aventis Deutschland GmbH. Decision date: 05/03/2026